AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL
· Real-Time Price · USD
2.50
-0.11 (-4.21%)
At close: May 01, 2025, 3:59 PM
2.48
-0.61%
After-hours: May 01, 2025, 06:19 PM EDT
AbCellera Biologics Revenue
AbCellera Biologics reported an annual revenue of $28.83M, reflecting a -24.17% growth. For the quarter ending December 31, 2024, AbCellera Biologics generated $5.05M in revenue.
Revenue (ttm)
$28.83M
Revenue Growth
-24.17%
Price / Sales Ratio
29.91
Revenue / Employee
$48.38K
Employees
596
Market Cap
743.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 28.83M | -24.17% |
| Dec 31, 2023 | 38.02M | -92.17% |
| Dec 31, 2022 | 485.42M | +29.38% |
| Dec 31, 2021 | 375.2M | +60.92% |
| Dec 31, 2020 | 233.16M | n/a |